arrow
M

Mark E. Sherman

mayo clinic
H指数:108
被引数:9.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EGFR/KIT-linked proliferative bias in normal breast lobules from matched non-Hispanic Black and White women is rapidly reversible by RTK inhibition

EGFR/KIT连锁的增殖偏倚在匹配的非西班牙裔黑人女性和白色女性正常乳腺小叶中,可通过RTK抑制迅速逆转

2026-02-270
OAAI
Associations of local breast density with patient characteristics and risk of breast cancer among women undergoing diagnostic breast biopsy

局部乳腺密度与患者特征及接受诊断性乳腺活检女性的乳腺癌风险关联

2026-02-040
OAAI
Postpartum breast cancer: evidence for a distinct phenotype

产后乳腺癌:存在独特表型的证据

2026-02-010
PRE
A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training

高通量生物物理抗体可开发性评估平台,用于支持AI/ML模型训练

MABS
IF7.3
2025-12-310
PRE
Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks

基于组织微阵列的良性乳腺小叶和乳腺癌数字空间分析:可行性、生物学一致性及跨平台基准

2025-11-270
OAAI
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013
2024-12-300
OAAI
Polygenic risk scores stratify breast cancer risk among women with benign breast disease

多基因风险评分对良性乳腺疾病女性的乳腺癌风险进行分层

2024-10-160
PRE
An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals

触手可及的基本目标: 实现多样性,公平和包容性的国家癌症研究所期刊

2023-10-090
OA